Mark Drayson

Professor Clinical Immunodiagnostics

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Mark Drayson is a faculty member in Clinical Immunodiagnostics at the University of Birmingham, UK. His research focuses on hematological malignancies, particularly multiple myeloma and its diagnostics, as well as the immune response in heavily treated patients. He has contributed significantly to recent studies exploring innovative treatments and diagnostic practices to improve patient outcomes in hematological cancers.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (13)

Janet Dunn

Professor of Clinical Trials and Head of Cancer trials

University of Warwick

UNITED KINGDOM

View details

Michelle Lawson

University of Sheffield

UNITED KINGDOM

View details

Gulnaz Iqbal

Associate Professor

University of Warwick

UNITED KINGDOM

View details

Guy Pratt

UNITED KINGDOM

View details

Gordon Cook

University of Leeds

UNITED KINGDOM

View details

Richard Neal

University of Exeter

UNITED KINGDOM

View details

Kamaraj Karunanithi

UNITED KINGDOM

View details

LONG XIE

Newcastle University

UNITED KINGDOM

View details

Harriet Hill

University of Birmingham

UNITED KINGDOM

View details

Catherine Atkin

NIHR Academic Clinical Lecturer

University of Birmingham

UNITED KINGDOM

View details

Dean Smith

Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Catherine Olivier

University of Leeds

UNITED KINGDOM

View details

Matthew W. Jenner

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Drayson

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry

Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services

Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial

An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the UK

Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial

Monoclonal gammopathy of increasing significance: time to screen?

Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial

Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open-label, randomised, phase III trial

Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial

COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.

Collaborators (13)

Janet Dunn

Michelle Lawson

Gulnaz Iqbal

Guy Pratt

Gordon Cook

Richard Neal

Kamaraj Karunanithi

LONG XIE

Harriet Hill

Catherine Atkin

Dean Smith

Catherine Olivier

Matthew W. Jenner

Make your next move.